Related Experiment Video
Updated: Jan 29, 2026
06:04
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
2.9K
Mycoplasma pneumoniae-associated Mucositis: A Recently Described Entity
Inês Zão1, Fani Ribeiro1, Valter Rocha2
1Internal Medicine Department, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal.
European Journal of Case Reports in Internal Medicine
|February 14, 2019
Summary
Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a distinct condition characterized by respiratory infection and severe mucositis. This case highlights MIRM
Area of Science:
- Infectious Diseases
- Pulmonology
- Dermatology
Background:
- Mycoplasma pneumoniae (MP) is a common pathogen causing respiratory infections and extrapulmonary complications.
- MP mucositis, recently termed Mycoplasma pneumoniae-induced rash and mucositis (MIRM), is an emerging clinical entity.
- MIRM is characterized by mucocutaneous lesions, predominantly mucositis with minimal or no skin involvement.
Purpose of the Study:
- To present a case of atypical pneumonia with significant mucositis diagnosed as MIRM.
- To discuss the clinical presentation, diagnosis, and management of MIRM.
- To differentiate MIRM from other severe mucocutaneous conditions like Stevens-Johnson syndrome.
Main Methods:
- Case report of a 46-year-old male with atypical pneumonia and exuberant mucositis.
- Diagnostic workup included serological assays for MP IgM.
- Treatment involved azithromycin, systemic corticosteroids, and supportive care.
Main Results:
- The patient presented with atypical pneumonia, severe mucositis, and conjunctival hyperaemia.
- Positive MP IgM serology supported the diagnosis.
- Complete resolution of pneumonia and mucositis was achieved with treatment.
Conclusions:
- MIRM is a distinct clinical entity associated with Mycoplasma pneumoniae infection.
- MIRM primarily involves mucositis with limited cutaneous manifestations.
- MIRM has a favorable prognosis, distinguishing it from Stevens-Johnson syndrome and erythema multiforme.
More Related Videos
Related Concept Videos
01:30Pneumonia I: Introduction
871
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
871
01:29Pneumonia II: Pathophysiology
2.9K
The pathophysiology of pneumonia involves the following steps:
2.9K
01:25Mucosal Barrier of the Stomach
2.3K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.3K
01:28Pneumonia IV: Management
810
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
810
01:30Pneumonia V: Nursing management and Prevention
3.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
01:30Pneumonia III: Complications and Assessment
851
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
851